Literature DB >> 29860638

Characterization of fibroblasts from hypertrophied right ventricle of pulmonary hypertensive rats.

Keisuke Imoto1, Muneyoshi Okada2, Hideyuki Yamawaki1.   

Abstract

Pulmonary arterial hypertension (PAH), which is characterized by an elevation of pulmonary arterial resistance, leads to a lethal right heart failure. It is an urgent issue to clarify the pathogenesis of PAH-induced right heart failure. The present study aimed to elucidate the characteristics of cardiac fibroblasts (CFs) isolated from hypertrophied right ventricles of monocrotaline (MCT)-induced PAH model rats. CFs were isolated from the right ventricles of MCT-injected rats (MCT-CFs) and saline-injected control rats (CONT-CFs). Expression of α-smooth muscle actin and collagen type I in MCT-CFs was lower than that in CONT-CFs. On the other hand, proliferation, migration, and matrix metalloproteinase (MMP)-9 production were significantly enhanced in MCT-CFs. In MCT-CFs, phosphorylation of extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK), and Ca2+/calmodulin-dependent protein kinase (CaMK) II was significantly enhanced. In addition to mRNA expression of Orai1, a Ca2+ release-activated Ca2+ channel, and stromal interaction molecules (STIM) 1, an endoplasmic reticulum Ca2+ sensor, the associated store-operated Ca2+ entry (SOCE) was significantly higher in MCT-CFs than CONT-CFs. Pharmacological inhibition of ERK1/2 pathway prevented the enhanced proliferation of MCT-CFs. The enhanced migration of MCT-CFs was prevented by a pharmacological inhibition of ERK1/2, JNK, CaMKII, or SOCE pathway. The enhanced MMP-9 production in MCT-CFs was prevented by a pharmacological inhibition of ERK1/2, CaMKII, or SOCE pathway but not JNK. The present results suggested that MCT-CFs exhibit proliferative and migratory phenotypes perhaps through multiple signaling pathways. This study for the first time determined the characteristics of CFs isolated from hypertrophied right ventricles of MCT-induced PAH model rats.

Entities:  

Keywords:  Cardiac fibroblasts; Migration; Proliferation; Pulmonary arterial hypertension; Right heart failure

Mesh:

Substances:

Year:  2018        PMID: 29860638     DOI: 10.1007/s00424-018-2158-4

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  37 in total

1.  Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Authors:  Marius M Hoeper; Tilmann Kramer; Zixuan Pan; Christina A Eichstaedt; Jens Spiesshoefer; Nicola Benjamin; Karen M Olsson; Katrin Meyer; Carmine Dario Vizza; Anton Vonk-Noordegraaf; Oliver Distler; Christian Opitz; J Simon R Gibbs; Marion Delcroix; H Ardeschir Ghofrani; Doerte Huscher; David Pittrow; Stephan Rosenkranz; Ekkehard Grünig
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  Altered fibroblast function following myocardial infarction.

Authors:  Christina E Squires; G Patricia Escobar; John F Payne; Robert A Leonardi; Danielle K Goshorn; Nina J Sheats; I Matthew Mains; Joseph T Mingoia; English C Flack; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2005-10       Impact factor: 5.000

3.  Calcium sensing receptor promotes cardiac fibroblast proliferation and extracellular matrix secretion.

Authors:  Xinying Zhang; Tiemin Zhang; Jichao Wu; Xiangjing Yu; Dan Zheng; Fan Yang; Ting Li; Lina Wang; Yajun Zhao; Shiyun Dong; Xin Zhong; Songbin Fu; Chang-qing Xu; Fanghao Lu; Wei-hua Zhang
Journal:  Cell Physiol Biochem       Date:  2014-02-25

4.  Acteoside inhibits PMA-induced matrix metalloproteinase-9 expression via CaMK/ERK- and JNK/NF-κB-dependent signaling.

Authors:  Yong Pil Hwang; Hyung Gyun Kim; Jae Ho Choi; Bong Hwan Park; Myung Ho Jeong; Tae Cheon Jeong; Hye Gwang Jeong
Journal:  Mol Nutr Food Res       Date:  2010-11-18       Impact factor: 5.914

5.  Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-κB-dependent MMP-9 and epithelial-mesenchymal transition expressions.

Authors:  Wai-Theng Lee; Tzong-Huei Lee; Chia-Hsiung Cheng; Ku-Chung Chen; Yen-Chou Chen; Cheng-Wei Lin
Journal:  Food Chem Toxicol       Date:  2015-02-02       Impact factor: 6.023

6.  IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes.

Authors:  Cheng-Ying Wu; Hsi-Lung Hsieh; Chi-Chin Sun; Chuen-Mao Yang
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

7.  Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.

Authors:  Subhendu Mukhopadhyay; Hidayatullah G Munshi; Suman Kambhampati; Antonella Sassano; Leonidas C Platanias; M Sharon Stack
Journal:  J Biol Chem       Date:  2004-06-04       Impact factor: 5.157

8.  Acetylsalicylic acid inhibits IL-18-induced cardiac fibroblast migration through the induction of RECK.

Authors:  Jalahalli M Siddesha; Anthony J Valente; Siva S V P Sakamuri; Jason D Gardner; Patrice Delafontaine; Makoto Noda; Bysani Chandrasekar
Journal:  J Cell Physiol       Date:  2014-07       Impact factor: 6.384

9.  Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats.

Authors:  Keisuke Imoto; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2017-05-11       Impact factor: 1.267

10.  NGF accelerates cutaneous wound healing by promoting the migration of dermal fibroblasts via the PI3K/Akt-Rac1-JNK and ERK pathways.

Authors:  Ji-Cai Chen; Bei-Bei Lin; Hou-Wen Hu; Cai Lin; Wen-Yang Jin; Fa-Biao Zhang; Yan-An Zhu; Cai-Jiao Lu; Xiao-Jie Wei; Rui-Jie Chen
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

View more
  1 in total

Review 1.  Interactive Roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases.

Authors:  Lan Wang; Roman G Ginnan; Yong-Xiao Wang; Yun-Min Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.